Consider joining MACrO2, a MAC clinical research study (MAC clinical trial). MACrO2 is for people with Mycobacterium avium complex (MAC) lung disease that has not responded to prescribed antibiotic medications.

MAC is a type of nontuberculous mycobacteria (NTM) lung disease.